SEARCH

SEARCH BY CITATION

References

  • Ahmad S, Khan Z, Mustafa AS & Khan ZU (2002) Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 40: 24832489.
  • Al-Fattani MA & Douglas LJ (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55: 9991008.
  • Alvarez-Lerma F, Nollas-Salas J, León C, Palomar M, Jordá R, Carrasco N & Bobillo F (2003) Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29: 10691076.
  • Andes D, Nett J, Oschel P, Albrecht R, Marchillo K & Pitula A (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72: 60236031.
  • Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR & López-Ribot JL (2002) In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46: 35913596.
  • Baillie GS & Douglas LJ (1999) Role of dimorphism in the development of Candidaalbicans biofilms. J Med Microbiol 48: 671679.
  • Barchiesi F, Calabrese D, Sanglard D, Falconi Di, Francesco L, Caselli F, Giannini D, Giacometti A, Gavaudan S & Scalise G (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44: 15781584.
  • Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F & Esposito R (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect 12: 7580.
  • Cao YY, Cao YB, Xu Z, Ying K, Li Y, Xie Y, Zhu ZY, Chen WS & Jiang YY (2005) cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 49: 584589.
  • Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 53855394.
  • Chandra J, Patel JD, Li J, Zhou G, Mukherjee PK, McCormick TS, Anderson JM & Ghannoum MA (2005) Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 71: 87958801.
  • Choi HW, Shin JH, Jung SI, Park KH, Cho D, Kee SJ, Shin MG, Suh SP & Ryang DW (2007) Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob Agents Chemother 51: 15201523.
  • Colombo AL, Nucci M, Park BJ, Noue'r SA, Arthington-Skaggs B, Matta DA & Warnock DMorgan J for the Brazilian Network Candidemia Study (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44: 28162823.
  • Costa SF, Marinho I, Araujo EA, Manrique AE, Medeiros EA & Levin AS (2000) Nosocomial fungaemia: a 2-year prospective study. J Hosp Infect 45: 6972.
  • Davies DG & Geesey GG (1995) Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol 61: 860867.
  • Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167193.
  • Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 3036.
  • Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM & D'Enfert C (2004) Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 3: 536545.
  • Godoy P, Tiraboschi IN, Severo LC, Bustamante B, Calvo B, Almeida LP, Matta DA & Colombo AL (2003) Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals. Mem Inst Oswaldo Cruz 98: 401405.
  • Goldani LZ & Mário PSS (2003) Candida tropicalis fungemia in a tertiary care hospital. J Infect 46: 155160.
  • Hajjeh RA, Sofair AN, Harrison LH et al. (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42: 15191527.
  • Hawser SP & Douglas LJ (1994) Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62: 915921.
  • Hawser SP & Douglas LJ (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39: 21282131.
  • Hoyer LL, Scherer S, Shatzman AR & Livi GP (1995) Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol Microbiol 15: 3954.
  • Jain N, Kohli R, Cook E, Gialanella P, Chang T & Fries BC (2007) Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 73: 16931703.
  • Jain P, Khan ZK, Bhattacharya E & Ranade SA (2001) Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans. Diagn Microbiol Infect Dis 41: 113119.
  • Jang SJ, Han HL, Lee SH et al. (2005) PFGE-Based epidemiological study of an outbreak of Candida tropicalis candiduria: the importance of medical waste as a reservoir of nosocomial infection. Jpn J Infect Dis 58: 263267.
  • Kauffman CA Vazquez JA & National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group et al. (2000) Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30: 1418.
  • Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP & Raad II (2001) Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33: 16761681.
  • Kuhn DM, Chandra J, Mukherjee PK & Ghannoum MA (2002a) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878888.
  • Kuhn DM, George T, Chandra J, Mukherjee PK & Ghannoum MA (2002b) Antifungal susceptibility of Candida biofilms: unique efficacy of amphoterecin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 17731780.
  • Kumamoto CA & Vinces MD (2005) Alternative Candida albicans lifestyles: growth on surfaces. Ann Rev Microbiol 59: 113133.
  • Leung AYH, Chim CS, Ho PL, Cheng VCC, Yuen KY, Lie AKW, AU WY, Liang R & Kwong YL (2002) Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect 50: 316319.
  • McGinnis MR, Padhye AA & Ajello L (1974) Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile distilled water. Appl Microbiol 28: 218222.
  • Melo AS, Colombo AL & Arthington-Skaggs BA (2007) Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 51: 30813088.
  • Mukherjee PK, Chandra J, Kuhn DM & Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71: 43334340.
  • Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J & Agabian NM (2005) Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 4: 15621573.
  • National Committee For Clinical Laboratory Standards – NCCLS (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards. Villanova, PA.
  • Nucci M & Colombo AL (2007) Candidemia due to Candida tropicalis: clinical, epidemiologic and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58: 7782.
  • Parahitiyawa NB, Samaranayake YH, Samaranayake LP, Ye J, Tsang PWK, Cheung BPK, Yau JYY & Yeung SKW (2006) Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 114: 298306.
  • Pinto PM, Weikert-Oliveira RCB, Lyon J, Cury VF, Arantes RR, Koga-Ito C & Resende MA (2006) In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Microbiol Res doi: DOI: 10.1016/j.micres.2006.08.007.
  • Ramage G, VandeWalle K, Wickes BL & Lópes-Ribot JL (2001a) Biofilm formation by Candida dubliniensis. J Clin Microbiol 39: 32343240.
  • Ramage G, VandeWalle K, Wickes BL & López-Ribot JL (2001b) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 24752479.
  • Ramage G, VandeWalle K, Wickes BL & López-Ribot JL (2001c) Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18: 163170.
  • Ramage G, Bachmann S, Patterson TF, Wickes BL & López-Ribot JL (2002a) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973980.
  • Ramage G, VandeWalle K, Bachmann SP, Wickes BL & López-Ribot JL (2002b) In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 46: 36343636.
  • Ramage G, Martinez JP & López-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979986.
  • Rho J, Shin JH, Song JW, Park MR, Kee SJ, Jang SJ, Park YK, Suh SP & Ryang DW (2004) Molecular investigation of two consecutive nosocomial clusters of Candida tropicalis candiduria using pulsed-field gel electrophoresis. J Microbiol 42: 8086.
  • Ruhnke M (2006) Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7: 495504.
  • Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S & Ghannoum MA (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48: 17271732.
  • Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, Suh SP & Ryang DW (2002) Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40: 12441248.
  • Soll DR (2002) Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Tropica 81: 101110.
  • Suzuki T, Omi K, Ito T, Takata T, Kikutsugi H, Fujimura T, Kono K & Kamihara T (2006) Ethanol-induced pseudohyphal transition in the cells of Candida tropicalis: participation of phosphoinositide signal transduction. FEMS Yeast Res 6: 177185.
  • Tani Y, Yamada Y & Kamihara T (1979) Morphological change in Candida tropicalis pK 233 caused by ethanol and its prevention by myo-inositol. Biochem Biophys Res Commun 91: 351355.
  • Vandeputte P, Larcher G, Berges T, Renier G, Chabasse D & Bouchara JP (2005) Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 49: 46084615.
  • Vigouroux S, Morin O, Moreau P, Harousseau JL & Milpied N (2006) Candidemia in patients with hematologic malignancies: analysis of 7 years experience in a single center. Haematologica 91: 137138.
  • Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR & Otto M (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279: 5488154886.
  • Weinberger M, Leibovici L, Perez S et al. (2005) Characteristics of candidaemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect 61: 146154.
  • Wimpenny J, Manz W & Szewzyk U (2000) Heterogeneity in biofilms. FEMS Microbiol Rev 24: 661671.
  • Yang YL, Ho YA, Cheng HH, Ho M & Lo HJ (2004) Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 25: 6064.
  • Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodrigues-Zas SL, Kwast KE, Ghannoum MA & Hoyer LL (2007) Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 153: 23732385.